Oncology nurse professionals play a key role in the management of myeloproliferative neoplasms (MPNs), including diseases such as myelofibrosis (MF) and polycythemia vera (PV). This symposium will offer nurse professionals insight from their expert colleagues on the modern treatment of MPNs, the role of new agent classes such as JAK inhibitors, and recommendations on how to optimally educate patients on the nature and clinical burden of diseases such as MF or PV.
This activity is supported by an educational grant from Incyte Corporation.
